Factors associated with the use of horme replacement therapy among older women [2]

Age and Ageing

Volumn 32, Issue 6, 2003, Pages 675-678

  Cornuz, Jacques ^a,b   Krieg, Marc Antoine ^a   Sandini, Lorenzo ^a   Ruffieux, Christiane ^b   Van Melle, Guy ^b   Burckhardt, Peter ^a   Buche D ^c   Dambacher, M ^d   Hartl, F ^e   Hauselmann H ^f   Lippuner, K ^g   Neff, M ^h   Pancaldi, P ⁱ   Rizzoli, R ^j   Tanzi, F ^k   Theiler, R ^c   Tyndall, A ^e   Wimpfheimer, C ^l  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c State Hospital   (Switzerland)

^d BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h Osteoporosis Center   (Switzerland)

ⁱ Osteoporosis Center   (Switzerland)

^j UNIVERSITY HOSPITAL   (Switzerland)

^k Osteoporosis Center   (Switzerland)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ESTROGEN; PROGESTERONE; VITAMIN D;

AGED; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE RADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ESTROGEN THERAPY; FEMALE; FRAGILITY FRACTURE; GERIATRIC CARE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MARRIAGE; MEDICAL INSTRUMENTATION; MENOPAUSAL SYNDROME; MULTICENTER STUDY; OSTEOPOROSIS; PATIENT INFORMATION; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; SOCIAL ASPECT; SOCIAL STATUS; STATISTICAL ANALYSIS; SUPPLEMENTATION; SWITZERLAND; VALIDATION PROCESS; VERTEBRA FRACTURE; ATTITUDE TO HEALTH; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; HEALTH SURVEY; PATHOLOGIC FRACTURE; POSTMENOPAUSE OSTEOPOROSIS; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME; UTILIZATION REVIEW;

AGED; ATTITUDE TO HEALTH; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, SPONTANEOUS; HEALTH SURVEYS; HIP FRACTURES; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; SWITZERLAND; TREATMENT OUTCOME;

EID: 0344897694     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afg099b     Document Type: Letter

References (26)

1. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
2. Vandenbroucke JP. How much of the cardioprotective effect of postmenopausal estrogens is real? Epidemiology 1995; 6: 207-8.
3. Petitti DB. Coronary heart disease and estrogen replacement therapy: can compliance bias explain the results of observational studies? Ann Epidemiol 1994; 4: 115-8.
4. Barret-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115: 455-6.
5. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 254: 627-31.
6. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996; 143: 971-8.
7. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997; 145: 536-45.
8. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999; 130: 545-53.
9. Rödström K, Bengtsson C, Lissner L, Björkelund C. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden. Br Med J 1999; 319: 890-3.
10. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990; 163: 1438-44.
11. Cornuz J, Krieg MA, Burckhardt P. Evaluation suisse des méthodes de mesure du risque de fracture ostéoporotique. Bull méd suisses 1999; 80: 352-5.
12. Krieg MA, Cornuz J, Büche D et al. Quality controls for two heel bone ultrasound used in the SEMOF study. J Clin Densitom 2002; 5: 335-41.
13. Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke established populations for epidemiologic studies of the elderly (EPESE). J Am Geriatr Soc 1996; 44: 1-6.
14. Sourander L, Rajala T, Rãihã I, Mäkinen J, Erkkola R, Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on estrogen replacement therapy. Lancet 1998; 352: 1965-69.
15. Ervin RB, Wright DW, Kennedy-Stephenson J. Use of dietary supplements in the United States, 1988-1994. Vital Health Stat 2000; 11: 244-56.
16. Mosca L, Collins P, Herrington DM et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499-503.
17. Office fé dé ral de la statistique. Swiss Health Survey. Neuchâtel: Office fé dé ral de la statistique, 1999.
18. Luoto R, Kaprio J, Uuetela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol 1983; 117: 651-8.
19. Levi F, Lucchini F, Pasche C, La Vecchia C. Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk. Eur J Cancer Prev 1996; 5: 259-66.
20. Colditz GA, Martin P, Stampfer MJ et al. Validation of questionnaire information on risk factors and disease outcome in a prospective cohort study of women. Am J Epidemiol 1986; 123: 894-900.
21. Goodman MT, Nomura AMY, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990: 131: 815-25.
22. Jannaussch Sowers MR. Consistency of perimenopausal estrogen use reporting by women in a population-based study. Maturitas 1992; 14: 161-9.
23. Honkanen K, Honkanen R, Heikkinen L, Heikki K, Saarikoski S. Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol 1999; 150: 511-16.
24. Jain MG, Rohan TE, Howe GR. Agreement of self-reported use of menopausal hormone replacement therapy with physician reports. Epidemiology 1999; 10: 260-3.
25. Merlo J, Berglund G, Wirfält E et al. Self-administrated questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol 2000; 152: 788-92.
26. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279: 688-95.